A sensitive and specific chromogenic assay for the detection of "functional FVIII inhibitors"

被引：0
|
作者：
Ghosh, K. [1 ]
Pinto, P. [1 ]
Kulkarni, B. [1 ]
Shetty, S. [1 ]
机构：
[1] King Edward Mem Hosp, Natl Inst Immunohaematol ICMR, Dept Haemostasis & Thrombosis, Bombay, Maharashtra, India
来源：
HAEMOPHILIA | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [31] THE DEVELOPMENT OF A RAPID AND SENSITIVE CHROMOGENIC HEPARIN ASSAY FOR CLINICAL USE
    WAGENVOORD, RJ
    HENDRIX, HH
    KOLDE, HJ
    HEMKER, HC
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 930 - 930
  • [32] DEVELOPMENT OF A RAPID AND SENSITIVE CHROMOGENIC HEPARIN ASSAY FOR CLINICAL USE
    WAGENVOORD, RJ
    HENDRIX, HH
    KOLDE, HJ
    HEMKER, HC
    HAEMOSTASIS, 1993, 23 (01) : 26 - 37
  • [33] SPECIFIC AND SENSITIVE DETECTION OF PROTEINASE-INHIBITORS AFTER ELECTROPHORESIS
    HAUSSNER, K
    WEDER, JKP
    AGRICULTURE, FOOD CHEMISTRY AND THE CONSUMER, VOLS 1 AND 2: THE CONSUMER AND FOOD, ANALYTICAL FOOD CHEMISTRY AND AGRICULTURAL PRODUCTION, BIOTECHNOLOGY AND BIOASSAYS - IMPACT OF TECHNOLOGY ON FOOD QUALITY, FOOD CHEMISTRY AND QUALITY ASSURANCE, 1989, : 185 - 189
  • [34] EVALUATION OF A CHROMOGENIC SUBSTRATE ASSAY FOR INHIBITORS OF BETA-FXIIA
    GALLIMORE, MJ
    FUHRER, G
    HELLER, W
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 301 - 301
  • [35] Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors
    Payne, Amanda B.
    Miller, Connie H.
    Ellingsen, Dorothy
    Driggers, Jennifer
    Boylan, Brian
    Bean, Christopher J.
    HAEMOPHILIA, 2019, 25 (05) : E342 - E344
  • [36] "A rapid, sensitive, and specific assay to measure tissue factor activity based on chromogenic determination of thrombin generation": reply
    Osterud, Bjarne
    Latysheva, Nadezhda
    Hansen, John-Bjarne
    Snir, Omri
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (04) : 1062 - 1063
  • [37] Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients
    Pouplard, C.
    Ternisien, C.
    Desconclois, C.
    Lasne, D.
    Aillaud, M. -F.
    Caron, C.
    HAEMOPHILIA, 2016, 22 (02) : E101 - E103
  • [38] AN IMPROVEMENT OF FVIII-C CHROMOGENIC METHOD WITH COMBINATION USE OF THE SPECIFIC SYNTHETIC THROMBIN INHIBITORS, MD805 AND I-2581
    IKESAWA, K
    YAMASHITA, T
    OHARA, T
    TAKEMOTO, K
    MIMURA, K
    MATSUOKA, A
    OKAMOTO, S
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 251 - 251
  • [39] RELATIONSHIP BETWEEN ONE-STAGE AND CHROMOGENIC FVIII ASSAY DISCREPANCIES AND GENETIC ANALYSIS OF FVIII GENE IN PATIENTS WITH NON-SEVERE HAEMOPHILIA A
    Obregon, J.
    Calvo Villas, J. M.
    Marco Rico, A.
    Herrero Martin, S.
    Urena, L. E.
    Lopez Jaime, F. J.
    Diaz Jordan, B.
    Garcia Diaz, C.
    Jurado Herrera, S.
    Perez Gonzalez, N. F.
    Garcia Candel, F.
    Marco Vera, P.
    Fernandez Bello, I.
    Montano Brioso, A.
    HAEMOPHILIA, 2023, 29 : 26 - 27
  • [40] Laboratory detection of inhibitors to FVIII and other clotting factors
    Verbruggen, R.
    HAEMOPHILIA, 2010, 16 : 82 - 82
12345